Differences in MicroRNA Expression in Firefighters Responding to a Train Derailment and Fire in East Palestine, Ohio
Abstract
1. Introduction
2. Results
2.1. Descriptive Statistics
2.2. miRNA Expression: Comparing Exposure Groups
2.3. Pathway Enrichment
3. Discussion
4. Materials and Methods
4.1. Cohort Recruitment and Study Population
4.2. MiRNA Analysis
4.3. Statistical Analysis
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| WUI | Wildland/urban interface |
| FFCCS | Firefighter Cancer Cohort Study |
| miRNA | microRNA |
| miEAA | microRNA Enrichment Analysis and Annotation |
| BMI | Body mass index |
References
- Demers, P.A.; DeMarini, D.M.; Fent, K.W.; Glass, D.C.; Hansen, J.; Adetona, O.; Andersen, M.H.; Freeman, L.E.B.; Caban-Martinez, A.J.; Daniels, R.D.; et al. Carcinogenicity of occupational exposure as a firefighter. Lancet Oncol. 2022, 23, 985–986. [Google Scholar] [CrossRef]
- Akhtar, U.S.; Keir, J.L.; Matschke, D.; White, P.; Blais, J.M. Occupational exposure to polycyclic aromatic hydrocarbons (PAHs) by firefighters. Toxicol. Lett. 2016, 259, S211. [Google Scholar] [CrossRef]
- Baxter, C.S.; Hoffman, J.D.; Knipp, M.J.; Reponen, T.; Haynes, E.N. Exposure of firefighters to particulates and polycyclic aromatic hydrocarbons. J. Occup. Environ. Hyg. 2014, 11, D85–D91. [Google Scholar] [CrossRef]
- Alharbi, B.H.; Pasha, M.J.; Al-Shamsi, M.A.S. Firefighter exposures to organic and inorganic gas emissions in emergency residential and industrial fires. Sci. Total Environ. 2021, 770, 145332. [Google Scholar] [CrossRef]
- Burgess, J.L.; Fisher, J.M.; Nematollahi, A.; Jung, A.M.; Calkins, M.M.; Graber, J.M.; Grant, C.C.; Beitel, S.C.; Littau, S.R.; Gulotta, J.J.; et al. Serum per- and polyfluoroalkyl substance concentrations in four municipal US fire departments. Am. J. Ind. Med. 2022, 66, 411–423. [Google Scholar] [CrossRef]
- Barros, B.; Oliveira, M.; Morais, S. Firefighters’ occupational exposure: Contribution from biomarkers of effect to assess health risks. Environ. Int. 2021, 156, 106704. [Google Scholar] [CrossRef]
- Kwak, K.; Kim, B.K.; Jang, T.W.; Sim, C.S.; Ahn, Y.S.; Choi, K.S.; Jeong, K.S. Association between Shift Work and Neurocognitive Function among Firefighters in South Korea: A Prospective Before-After Study. Int. J. Environ. Res. Public Health 2020, 17, 4647. [Google Scholar] [CrossRef]
- Boffetta, P.; Hall, C.B.; Todd, A.C.; Goldfarb, D.G.; Schymura, M.J.; Li, J.; Cone, J.E.; Zeig-Owens, R. Cancer risk among World Trade Center rescue and recovery workers: A review. CA A Cancer J. Clin. 2022, 72, 308–314. [Google Scholar] [CrossRef]
- Aldrich, T.K.; Vossbrinck, M.; Zeig-Owens, R.; Hall, C.B.; Schwartz, T.M.; Moir, W.; Webber, M.P.; Cohen, H.W.; Nolan, A.; Weiden, M.D.; et al. Lung Function Trajectories in World Trade Center-Exposed New York City Firefighters Over 13 Years: The Roles of Smoking and Smoking Cessation. Chest 2016, 149, 1419–1427. [Google Scholar] [CrossRef]
- Aldrich, T.K.; Weakley, J.; Dhar, S.; Hall, C.B.; Crosse, T.; Banauch, G.I.; Weiden, M.D.; Izbicki, G.; Cohen, H.W.; Gupta, A.; et al. Bronchial Reactivity and Lung Function After World Trade Center Exposure. Chest 2016, 150, 1333–1340. [Google Scholar] [CrossRef]
- Clouston, S.A.P.; Mann, F.D.; Meliker, J.; Kuan, P.F.; Kotov, R.; Richmond, L.L.; Babalola, T.; Kritikos, M.; Yang, Y.; Carr, M.A.; et al. Incidence of Dementia Before Age 65 Years Among World Trade Center Attack Responders. JAMA Netw. Open 2024, 7, e2416504. [Google Scholar] [CrossRef] [PubMed]
- Kritikos, M.; Franceschi, A.M.; Vaska, P.; Clouston, S.A.P.; Huang, C.; Salerno, M.; Deri, Y.; Tang, C.; Pellecchia, A.; Santiago-Michels, S.; et al. Assessment of Alzheimer’s Disease Imaging Biomarkers in World Trade Center Responders with Cognitive Impairment at Midlife. World J. Nucl. Med. 2022, 21, 267–275. [Google Scholar] [CrossRef]
- Nadler, D.L.; Zurbenko, I.G. Estimating Cancer Latency Times Using a Weibull Model. Adv. Epidemiol. 2014, 2014, 746769. [Google Scholar] [CrossRef]
- Smith, M.T.; Guyton, K.Z.; Kleinstreuer, N.; Borrel, A.; Cardenas, A.; Chiu, W.A.; Felsher, D.W.; Gibbons, C.F.; Goodson, W.H., 3rd; Houck, K.A.; et al. The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them. Cancer Epidemiol. Biomark. Prev. 2020, 29, 1887–1903. [Google Scholar] [CrossRef]
- Testa, U.; Pelosi, E. MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias. Leuk. Lymphoma 2015, 56, 1466–1474. [Google Scholar] [CrossRef]
- Mi, Y.; Ren, K.; Zou, J.; Bai, Y.; Zhang, L.; Zuo, L.; Okada, A.; Yasui, T. The Association Between Three Genetic Variants in MicroRNAs (Rs11614913, Rs2910164, Rs3746444) and Prostate Cancer Risk. Cell. Physiol. Biochem. 2018, 48, 149–157. [Google Scholar] [CrossRef] [PubMed]
- Kanwal, R.; Gupta, S. Epigenetic modifications in cancer. Clin. Genet. 2012, 81, 303–311. [Google Scholar] [CrossRef] [PubMed]
- Nesset, K.A.; Perri, A.M.; Mueller, C.R. Frequent promoter hypermethylation and expression reduction of the glucocorticoid receptor gene in breast tumors. Epigenetics 2014, 9, 851–859. [Google Scholar] [CrossRef]
- Darwiche, N. Epigenetic mechanisms and the hallmarks of cancer: An intimate affair. Am. J. Cancer Res. 2020, 10, 1954–1978. [Google Scholar]
- Smith, M.T.; Guyton, K.Z.; Gibbons, C.F.; Fritz, J.M.; Portier, C.J.; Rusyn, I.; DeMarini, D.M.; Caldwell, J.C.; Kavlock, R.J.; Lambert, P.F.; et al. Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis. Environ. Health Perspect. 2016, 124, 713–721. [Google Scholar] [CrossRef]
- Carter, J.V.; Galbraith, N.J.; Yang, D.; Burton, J.F.; Walker, S.P.; Galandiuk, S. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: A systematic review and meta-analysis. Br. J. Cancer 2017, 116, 762–774. [Google Scholar] [CrossRef]
- Calin, G.A.; Croce, C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6, 857–866. [Google Scholar] [CrossRef]
- Jung, A.M.; Zhou, J.; Beitel, S.C.; Littau, S.R.; Gulotta, J.J.; Wallentine, D.D.; Moore, P.K.; Burgess, J.L. Longitudinal evaluation of whole blood miRNA expression in firefighters. J. Expo. Sci. Environ. Epidemiol. 2021, 31, 900–912. [Google Scholar] [CrossRef]
- Jeong, K.S.; Zhou, J.; Griffin, S.C.; Jacobs, E.T.; Dearmon-Moore, D.; Zhai, J.; Littau, S.R.; Gulotta, J.; Moore, P.; Peate, W.F.; et al. MicroRNA Changes in Firefighters. J. Occup. Environ. Med. 2018, 60, 469–474. [Google Scholar] [CrossRef]
- Goodrich, J.M.; Furlong, M.A.; Urwin, D.J.; Gabriel, J.; Hughes, J.; Jung, A.M.; Calkins, M.M.; DuBose, K.N.; Caban-Martinez, A.J.; Solle, N.S.; et al. Epigenetic Modifications Associated With Wildland-Urban Interface (WUI) Firefighting. Environ. Mol. Mutagen. 2025, 66, 22–33. [Google Scholar] [CrossRef]
- IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 97. 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). IARC Monogr. Eval. Carcinog. Risks Hum. 2008, 97, 3–471. [Google Scholar]
- IARC. Benzene; IARC: Lyon, France, 2018. [Google Scholar]
- Feng, N.N.; Fang, Y.; Zhang, Y.N.; Xu, X.W.; Li, Y.; Wang, J.W.; Li, Y.L.; Brandt-Rauf, P.; Xia, Z.L. Analysis of microRNA expression and micronuclei frequency in workers exposed to vinyl chloride monomer in China. Epigenomics 2017, 9, 1093–1104. [Google Scholar] [CrossRef] [PubMed]
- Burgess, J.L.; Beitel, S.C.; Calkins, M.M.; Furlong, M.A.; Louzado Feliciano, P.; Kolar Gabriel, J.; Grant, C.; Goodrich, J.M.; Graber, J.M.; Healy, O.; et al. The Fire Fighter Cancer Cohort Study: Protocol for a Longitudinal Occupational Cohort Study. JMIR Res. Protoc. 2025, 14, e70522. [Google Scholar] [CrossRef] [PubMed]
- Su, Y.; Ni, Z.; Wang, G.; Cui, J.; Wei, C.; Wang, J.; Yang, Q.; Xu, Y.; Li, F. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p. Int. Immunopharmacol. 2012, 13, 468–475. [Google Scholar] [CrossRef]
- Zheng, J.; Zhou, Y.; Li, X.J.; Hu, J.M. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 6839–6848. [Google Scholar] [CrossRef]
- Jin, L.L.; Zhang, S.J.; Lu, G.X.; Lv, F.; Shang, R.; Yang, J. miR-574-3p inhibits proliferation and invasion in esophageal cancer by targeting FAM3C and MAPK1. Kaohsiung J. Med. Sci. 2020, 36, 318–327. [Google Scholar] [CrossRef] [PubMed]
- Manterola, L.; Guruceaga, E.; Gállego Pérez-Larraya, J.; González-Huarriz, M.; Jauregui, P.; Tejada, S.; Diez-Valle, R.; Segura, V.; Samprón, N.; Barrena, C.; et al. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro Oncol. 2014, 16, 520–527. [Google Scholar] [CrossRef]
- Ma, J.; Wei, H.; Li, X.; Qu, X. Hsa-miR-149-5p Suppresses Prostate Carcinoma Malignancy by Suppressing RGS17. Cancer Manag. Res. 2021, 13, 2773–2783. [Google Scholar] [CrossRef]
- Tian, P.; Yan, L. Inhibition of MicroRNA-149-5p Induces Apoptosis of Acute Myeloid Leukemia Cell Line THP-1 by Targeting Fas Ligand (FASLG). Med. Sci. Monit. 2016, 22, 5116–5123. [Google Scholar] [CrossRef]
- Ning, B.; Chiu, D.J.; Pfefferkorn, R.M.; Kefella, Y.; Kane, E.; Reyes-Ortiz, V.; Liu, G.; Zhang, S.; Liu, H.; Sultan, L.; et al. Epithelial miR-149-5p up-regulation is associated with immune evasion in progressive bronchial premalignant lesions. bioRxiv 2025. [Google Scholar] [CrossRef]
- IARC. Occupational Exposure as a Firefighter; IARC: Lyon, France, 2023; p. 132. [Google Scholar]
- Kim, Y.T.; Kim, W.; Bae, M.-j.; Choi, J.E.; Kim, M.-J.; Oh, S.S.; Park, K.S.; Park, S.; Lee, S.-K.; Koh, S.-B.; et al. The effect of polycyclic aromatic hydrocarbons on changes in the brain structure of firefighters: An analysis using data from the Firefighters Research on Enhancement of Safety & Health study. Sci. Total Environ. 2022, 816, 151655. [Google Scholar] [CrossRef]
- Feng, N.; Zheng, G.; Hao, Y.; Li, Y.; Xu, Y.; Xu, X.; Zhang, G.; Wang, J.; Li, Y.; Brandt-Rauf, P.; et al. Mutations in apoptotic genes and micronucleus occurrence in vinyl chloride-exposed workers in China. Environ. Mol. Mutagen. 2017, 58, 39–45. [Google Scholar] [CrossRef]
- Zhao, X.; Hao, Y.; Wang, Q.; Shen, Y.; Cheng, Y.; Li, B.; Gao, Y.; Wang, T.; Qiu, Y. Novel deoxyribonucleic acid methylation perturbations in workers exposed to vinyl chloride. Toxicol. Ind. Health 2022, 38, 377–388. [Google Scholar] [CrossRef]
- Girardi, P.; Barbiero, F.; Baccini, M.; Comba, P.; Pirastu, R.; Mastrangelo, G.; Ballarin, M.N.; Biggeri, A.; Fedeli, U. Mortality for Lung Cancer among PVC Baggers Employed in the Vinyl Chloride Industry. Int. J. Environ. Res. Public Health 2022, 19, 6246. [Google Scholar] [CrossRef] [PubMed]
- Schaffer, D.H.; Poole, N.D.; Downs, J.W. Vinyl Chloride Toxicity. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2025. [Google Scholar]
- Dai, K.; Wang, C.; Yao, W.; Hao, C. Expression level and function analysis of serum miRNAs in workers with occupational exposure to benzene series. Chemosphere 2023, 313, 137460. [Google Scholar] [CrossRef] [PubMed]
- Li, S.; Song, F.; Lei, X.; Li, J.; Li, F.; Tan, H. hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p/TEP1 axis. Aging 2020, 12, 11517–11529. [Google Scholar] [CrossRef] [PubMed]
- Terry, M.B.; Delgado-Cruzata, L.; Vin-Raviv, N.; Wu, H.C.; Santella, R.M. DNA methylation in white blood cells: Association with risk factors in epidemiologic studies. Epigenetics 2011, 6, 828–837. [Google Scholar] [CrossRef] [PubMed]
- Leygo, C.; Williams, M.; Jin, H.C.; Chan, M.W.Y.; Chu, W.K.; Grusch, M.; Cheng, Y.Y. DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer. Dis. Markers 2017, 2017, 3726595. [Google Scholar] [CrossRef]
- Risso, D.; Ngai, J.; Speed, T.P.; Dudoit, S. Normalization of RNA-seq data using factor analysis of control genes or samples. Nat. Biotechnol. 2014, 32, 896–902. [Google Scholar] [CrossRef]
- Love, M.I.; Huber, W.; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014, 15, 550. [Google Scholar]
- Aparicio-Puerta, E.; Hirsch, P.; Schmartz, G.P.; Kern, F.; Fehlmann, T.; Keller, A. miEAA 2023: Updates, new functional microRNA sets and improved enrichment visualizations. Nucleic Acids Res. 2023, 51, W319–W325. [Google Scholar] [CrossRef]
- Backes, C.; Khaleeq, Q.T.; Meese, E.; Keller, A. miEAA: microRNA enrichment analysis and annotation. Nucleic Acids Res. 2016, 44, W110–W116. [Google Scholar] [CrossRef]
- Cui, C.; Zhong, B.; Fan, R.; Cui, Q. HMDD v4.0: A database for experimentally supported human microRNA-disease associations. Nucleic Acids Res. 2024, 52, D1327–D1332. [Google Scholar] [CrossRef] [PubMed]

| All Participants (n = 88) | Responded to the East Palestine Incident (n = 62) | Did Not Respond (n = 26) | ||||||
|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | p-Value * | ||
| Career Type | Career | 11 | 12.5% | 8 | 12.90% | 3 | 11.5% | |
| Volunteer | 67 | 76.1% | 46 | 74.20% | 21 | 80.8% | ||
| Both | 10 | 11.4% | 8 | 12.90% | 2 | 7.7% | 0.92 | |
| Sex | Male | 75 | 85.2% | 55 | 88.70% | 20 | 76.9% | |
| Female | 13 | 14.8% | 7 | 11.30% | 6 | 23.1% | 0.19 | |
| Smoking Status | Current | 11 | 12.5% | 9 | 14.50% | 2 | 7.7% | |
| Past | 11 | 12.5% | 9 | 14.50% | 2 | 7.7% | ||
| Never | 66 | 75.0% | 44 | 71.00% | 22 | 84.6% | 0.53 | |
| mean | SD | mean | SD | mean | SD | |||
| Age (years) | 41.3 | 14 | 41.9 | 13.4 | 40 | 15.7 | 0.6 | |
| BMI (kg/m2) | 31.4 | 6.9 | 32 | 7.2 | 29.8 | 5.7 | 0.14 | |
| Firefighting Years | 17.9 | 13.2 | 19.8 | 13.1 | 13.3 | 12.6 | 0.03 | |
| Subcategory | p-Value | Q-Value | Expected Number of miRNA | Observed Number of miRNA in this Pathway |
|---|---|---|---|---|
| Brain disease | 2.39 × 10−5 | 0.007 | 4.5 | 13 |
| Vascular diseases | 1.41 × 10−5 | 0.007 | 5.2 | 14 |
| Leukemia | 4.83 × 10−5 | 0.007 | 4.8 | 13 |
| Neurodegenerative diseases | 4.17 × 10−5 | 0.007 | 4.7 | 13 |
| Carcinoma | 1.52 × 10−4 | 0.009 | 4.4 | 12 |
| Eye disease | 1.31 × 10−4 | 0.009 | 3.6 | 11 |
| Lung cancer | 1.28 × 10−4 | 0.009 | 4.4 | 12 |
| Melanoma | 1.57 × 10−4 | 0.009 | 3.7 | 11 |
| Prader–Willi syndrome | 1.24 × 10−4 | 0.009 | 0.0 | 2 |
| Progesterone receptor positive breast cancer | 1.41 × 10−4 | 0.009 | 4.4 | 12 |
| Breast cancer | 1.80 × 10−4 | 0.009 | 6.3 | 14 |
| Prostate cancer | 1.96 × 10−4 | 0.009 | 3.8 | 11 |
| Hepatocellular carcinoma | 2.16 × 10−4 | 0.009 | 5.5 | 13 |
| Breast carcinoma | 2.84 × 10−4 | 0.011 | 1.5 | 7 |
| Bone disease | 3.87 × 10−4 | 0.014 | 3.3 | 10 |
| Familiar ovarian carcinoma | 4.36 × 10−4 | 0.014 | 3.4 | 10 |
| Li–Fraumeni syndrome | 4.11 × 10−4 | 0.014 | 0.0 | 2 |
| Diabetes mellitus | 6.27 × 10−4 | 0.019 | 3.5 | 10 |
| Malignant glioma | 9.26 × 10−4 | 0.027 | 3.7 | 10 |
| Solid-pseudopapillary neoplasm of pancreas | 0.001 | 0.032 | 1.8 | 7 |
| Alzheimer’s disease | 0.001 | 0.038 | 5.6 | 12 |
| Cervical squamous cell carcinoma | 0.002 | 0.038 | 1.4 | 6 |
| Glioblastoma | 0.002 | 0.038 | 4.7 | 11 |
| Acute myelocytic leukemia | 0.002 | 0.040 | 0.6 | 4 |
| Estrogen-receptor-negative breast cancer | 0.002 | 0.040 | 4.0 | 10 |
| Lung adenocarcinoma | 0.002 | 0.040 | 4.8 | 11 |
| Lymphoma | 0.002 | 0.040 | 3.3 | 9 |
| Pituitary neoplasms | 0.002 | 0.040 | 1.5 | 6 |
| Familial ovarian cancer | 0.002 | 0.044 | 3.4 | 9 |
| Progesterone receptor negative breast cancer | 0.002 | 0.045 | 4.1 | 10 |
| Liver cirrhosis | 0.003 | 0.049 | 0.6 | 4 |
| Osteosarcoma | 0.003 | 0.049 | 2.8 | 8 |
| Skin disease | 0.003 | 0.049 | 1.5 | 6 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Goodrich, J.M.; Xin, Y.; Beitel, S.C.; Gulotta, J.; Wang, L.; Thotakura, B.; Graber, J.M.; Urwin, D.; Mayer, A.C.; Jahnke, S.; et al. Differences in MicroRNA Expression in Firefighters Responding to a Train Derailment and Fire in East Palestine, Ohio. Epigenomes 2026, 10, 8. https://doi.org/10.3390/epigenomes10010008
Goodrich JM, Xin Y, Beitel SC, Gulotta J, Wang L, Thotakura B, Graber JM, Urwin D, Mayer AC, Jahnke S, et al. Differences in MicroRNA Expression in Firefighters Responding to a Train Derailment and Fire in East Palestine, Ohio. Epigenomes. 2026; 10(1):8. https://doi.org/10.3390/epigenomes10010008
Chicago/Turabian StyleGoodrich, Jaclyn M., Yaodong Xin, Shawn C. Beitel, John Gulotta, Lu Wang, Bhavya Thotakura, Judith M. Graber, Derek Urwin, Alexander C. Mayer, Sara Jahnke, and et al. 2026. "Differences in MicroRNA Expression in Firefighters Responding to a Train Derailment and Fire in East Palestine, Ohio" Epigenomes 10, no. 1: 8. https://doi.org/10.3390/epigenomes10010008
APA StyleGoodrich, J. M., Xin, Y., Beitel, S. C., Gulotta, J., Wang, L., Thotakura, B., Graber, J. M., Urwin, D., Mayer, A. C., Jahnke, S., Edwards, D. L., Grant, C., Ranganathan, S., & Burgess, J. L. (2026). Differences in MicroRNA Expression in Firefighters Responding to a Train Derailment and Fire in East Palestine, Ohio. Epigenomes, 10(1), 8. https://doi.org/10.3390/epigenomes10010008

